Standpoint Research Downgrades Juno Therapeutics (JUNO) to Hold
Tweet
Share
E-mailGet Alerts JUNO Hot Sheet
Price: $86.96 --0%
Rating Summary:
4 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
4 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Standpoint Research downgraded Juno Therapeutics (NASDAQ: JUNO) from Buy to Hold.
For an analyst ratings summary and ratings history on Juno Therapeutics click here. For more ratings news on Juno Therapeutics click here.
Shares of Juno Therapeutics closed at $53.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Deutsche Bank Downgrades Safestore Holdings Plc. (SAFE:LN) to Hold
- Deutsche Bank Downgrades CME Group (CME) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
